GREENYN BIOTECHNOLOGY CO LTDGREENYN BIOTECHNOLOGY CO LTDGREENYN BIOTECHNOLOGY CO LTD

GREENYN BIOTECHNOLOGY CO LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.10 B‬TWD
‪130.66 M‬TWD
‪800.51 M‬TWD
Beta (1Y)
0.05

About GREENYN BIOTECHNOLOGY CO LTD


CEO
Chia Feng Wu
Headquarters
Taichung
Founded
2012
ISIN
TW0006846009
FIGI
BBG016PTKWL8
Greenyn Biotechnology Co., Ltd. engages in the research, development, manufacture and sales of health food raw materials. Its products include solid-state antrodia cinnamomea mycelia, bitter gourd peptide, and 101 comprehensive vegetable and fruit fermentation broth. The company was founded on July 18, 2012 and is headquartered in Taichung, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6846 is 78.1 TWD — it hasn't changed in the past 24 hours. Watch GREENYN BIOTECHNOLOGY CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GREENYN BIOTECHNOLOGY CO LTD stocks are traded under the ticker 6846.
6846 stock has risen by 2.37% compared to the previous week, the month change is a 2.50% rise, over the last year GREENYN BIOTECHNOLOGY CO LTD has showed a −1.76% decrease.
We've gathered analysts' opinions on GREENYN BIOTECHNOLOGY CO LTD future price: according to them, 6846 price has a max estimate of 82.00 TWD and a min estimate of 82.00 TWD. Watch 6846 chart and read a more detailed GREENYN BIOTECHNOLOGY CO LTD stock forecast: see what analysts think of GREENYN BIOTECHNOLOGY CO LTD and suggest that you do with its stocks.
6846 reached its all-time high on Mar 7, 2023 with the price of 120.5 TWD, and its all-time low was 62.2 TWD and was reached on Jul 1, 2022. View more price dynamics on 6846 chart.
See other stocks reaching their highest and lowest prices.
6846 stock is 2.20% volatile and has beta coefficient of 0.05. Track GREENYN BIOTECHNOLOGY CO LTD stock price on the chart and check out the list of the most volatile stocks — is GREENYN BIOTECHNOLOGY CO LTD there?
Yes, you can track GREENYN BIOTECHNOLOGY CO LTD financials in yearly and quarterly reports right on TradingView.
GREENYN BIOTECHNOLOGY CO LTD is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
6846 earnings for the last quarter are 1.10 TWD per share, whereas the estimation was 1.10 TWD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 1.58 TWD per share. See more details about GREENYN BIOTECHNOLOGY CO LTD earnings.
GREENYN BIOTECHNOLOGY CO LTD revenue for the last quarter amounts to ‪208.00 M‬ TWD, despite the estimated figure of ‪208.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪244.50 M‬ TWD.
6846 net income for the last quarter is ‪28.93 M‬ TWD, while the quarter before that showed ‪24.93 M‬ TWD of net income which accounts for 16.08% change. Track more GREENYN BIOTECHNOLOGY CO LTD financial stats to get the full picture.
Yes, 6846 dividends are paid annually. The last dividend per share was 3.50 TWD. As of today, Dividend Yield (TTM)% is 4.49%. Tracking GREENYN BIOTECHNOLOGY CO LTD dividends might help you take more informed decisions.
GREENYN BIOTECHNOLOGY CO LTD dividend yield was 4.43% in 2023, and payout ratio reached 69.33%. The year before the numbers were 4.78% and 64.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GREENYN BIOTECHNOLOGY CO LTD EBITDA is ‪189.86 M‬ TWD, and current EBITDA margin is 23.08%. See more stats in GREENYN BIOTECHNOLOGY CO LTD financial statements.
Like other stocks, 6846 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GREENYN BIOTECHNOLOGY CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GREENYN BIOTECHNOLOGY CO LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GREENYN BIOTECHNOLOGY CO LTD stock shows the sell signal. See more of GREENYN BIOTECHNOLOGY CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.